https://www.selleckchem.com/products/vbit-4.html
Data from the Improving Outcomes and Antibiotic Stewardship for Patients with Bloodstream Infections Accelerate PhenoTest™ BC Kit (AXDX) Registry Study were analysed to determine the impact of rapid organism identification and antimicrobial susceptibility testing (AST) for Gram-positive bacteraemia. This multicentre, quasi-experimental study evaluated clinical and antimicrobial stewardship metrics following the implementation of AXDX. Data from hospitalized patients with bacteraemia were compared between groups, one that underwent testin
إعجاب
علق
شارك
